In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil

Cristina Barroso Hofer, Olivia Keiser, Marcel Zwahlen, Carla Sepulveda Lustosa, Ana Cristina Cisne Frota, Ricardo Hugo de Oliveira, Thalita F Abreu, Alice Weber Carvalho, Lucia Evangelista Araujo, Matthias Egger, Cristina Barroso Hofer, Olivia Keiser, Marcel Zwahlen, Carla Sepulveda Lustosa, Ana Cristina Cisne Frota, Ricardo Hugo de Oliveira, Thalita F Abreu, Alice Weber Carvalho, Lucia Evangelista Araujo, Matthias Egger

Abstract

Background: There are concerns about the effects of in utero exposure to antiretroviral drugs (ARVs) on the development of HIV-exposed but uninfected (HEU) children. The aim of this study was to evaluate whether in utero exposure to ARVs is associated with lower birth weight/height and reduced growth during the first 2 years of life.

Methods: This cohort study was conducted among HEU infants born between 1996 and 2010 in Tertiary children's hospital in Rio de Janeiro, Brazil. Weight was measured by mechanical scale, and height was measured by measuring board. Z-scores for weight-for-age (WAZ), length-for-age (LAZ) and weight-for-length were calculated. We modeled trajectories by mixed-effects models and adjusted for mother's age, CD4 cell count, viral load, year of birth and family income.

Results: A total of 588 HEU infants were included of whom 155 (26%) were not exposed to ARVs, 114 (19%) were exposed early (first trimester) and 319 (54%) later. WAZ were lower among infants exposed early compared with infants exposed later: adjusted differences were -0.52 (95% confidence interval [CI]: -0.99 to -0.04, P = 0.02) at birth and -0.22 (95% CI: -0.47 to 0.04, P = 0.10) during follow-up. LAZ were lower during follow-up: -0.35 (95% CI: -0.63 to -0.08, P = 0.01). There were no differences in weight-for-length scores. Z-scores of infants exposed late during pregnancy were similar to unexposed infants.

Conclusions: In HEU children, early exposure to ARVs was associated with lower WAZ at birth and lower LAZ up to 2 years of life. Growth of HEU children needs to be monitored closely.

Figures

Figure 1
Figure 1
Weight-for-age z-scores (WAZ), length-for-age z-scores (LAZ) and weight-for-length z-scores (WLZ) up to 24 months of life by antiretroviral drug (ARV) exposure during pregnancy: first trimester (earlier ARV), second or third trimester (later ARV) and no ARV. Results from mixed-effects linear regression models based on 358 (WAZ), 356 (LAZ) and 340 (WLZ) children; splines were introduced with knots at 4.5 and 9.6 months.

Source: PubMed

3
Abonnieren